Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chou C–T – Before the era of biologic agents, NSAIDs were only drugs proved to be useful in treating patients with SPA. However, approximately 20% are non–responder. From the serologic, synovial fluid and synovial pathology findings, TNF–alpha is highly associated with AS or other SPA. Early studies of anti–TNF–alpha therapy in SPA showed a very good efficacy for pain and inflammation as in RA. However, it is not certain for the biologic therapy to reduce the new bone formation in AS. This is still a treatment barrier but need to break through.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address